Here are the Form 4 insider transactions from abrdn Healthcare Investors (HQH) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow HQH and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HQH filings page.
abrdn Healthcare Investors (HQH) director Alan R. Goodson sold 242 shares of Common Stock at $19.3181 per share on October 6, 2026. His reported direct holdings following the sale were zero shares. The transaction is described as a sale in the open market or a private transaction. No Rule 10b5-1 plan is reported.
abrdn Healthcare Investors director Chris LaVictoire Mahai purchased 501 shares of Common Stock at $20.9600 per share on July 16, 2026. After this open-market transaction, the director directly owns 501.0000 shares of HQH. The filing indicates the trade was not made under a Rule 10b5-1 plan.